WCM
CLB icon

Wealthcare Capital Management’s Core Laboratories CLB Stock Holding History

Wealthcare Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-178
Closed -$5K – 180
2021
Q1 		$5K Buy
+178
New +$6.08K ﹤0.01% 374
2015
Q3 		– Sell
-14
Closed – – 268
2015
Q2 		$0 Sell
14
-17
-55% -$2.06K ﹤0.01% 470
2015
Q1 		$3K Buy
+31
New +$3.3K ﹤0.01% 739

Other funds holding CLB

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthcare Capital Management's CLB Position: Q2 2021 in Review

Wealthcare Capital Management sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 178 shares — an estimated $5K sold.

Wealthcare Capital Management first reported a position in CLB in Q1 2015 and held it in 3 quarters. The position peaked at $5K in Q1 2021. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Wealthcare Capital Management reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Capital Management sold 178 Core Laboratories shares in Q2 2021, an estimated $5K.
  • Wealthcare Capital Management first reported a position in Core Laboratories in Q1 2015 and held it in 3 quarters.
  • Wealthcare Capital Management's Core Laboratories position peaked at $5K in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Wealthcare Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.